Resources

ArsenalBio joins next-gen cell therapy field with $85M A round

ArsenalBio has exited stealth with $85 million to discover and develop cell therapies. The biotech aims to differentiate itself from the ever-growing pack of cell therapy startups with technology that enables the insertion of large DNA sequences without the use of...

read more

Artificial pancreas system shows promise in clinical trial

A clinical trial principally funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has found an artificial pancreas system could effectively control blood glucose levels in patients with type 1 diabetes. The closed-loop system,...

read more

EPFL develops electrode implant to restore hearing

Researchers at Ecole polytechnique fédérale de Lausanne (EPFL)’s Laboratory for Soft BioElectronic Interface (LSBI) are developing a conformable, electrode implant to restore hearing in those with a dysfunctional inner ear. The implant will provide...

read more

Ode to Patients

Due to meetings in London on a Friday and in Dortmund on the following Monday, I spent the weekend in London.  As I walked the streets appreciating its history, I could not help but think of the history of medicine, as well.  Images of leeches and...

read more

Leave No Stone Unturned: A Pipeline Story

Building a leading gene therapy pipeline in under two years (and a lot of air miles): how to persevere and make the calls that matter. Throughout a career in business development I’ve sat at every seat at the negotiating table, but I count my experience building...

read more

With eyes on IPO, muscular dystrophy startup names new CEO

The scientific founder and CEO of Cambridge startup Dyne Therapeutics has hired a new CEO — a former CFO with experience in public stock offerings. Read more. The post With eyes on IPO, muscular dystrophy startup names new CEO appeared first on Atlas Venture.

read more

Early Company Evolution – People, Pipeline, and Purse

“Time flies when you’re having fun.” That’s how I feel as I reflect on the first three years of the growth of Kyn Therapeutics. So much has happened since my R&D colleague Michelle Zhang and I moved into the seed space at Atlas Venture (see...

read more

Battery Charger IC Brings Longer Life to Wearables

Texas Instruments rolled out a new battery charger IC that boosts the run time of compact consumer and medical electronics while cutting charging times and filling up more of the battery's available capacity. The new switching battery

read more